Stay updated on Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now displayed, replacing Revision: v3.6.2. This appears to be an update to the document version without changes to the study content or its features.
    Difference
    0.0%
    Check dated 2026-07-05T14:47:08.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page's Revision label changed from v3.6.0 to v3.6.2, signaling a small update to the underlying software/content version.
    Difference
    0.0%
    Check dated 2026-06-28T08:57:32.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The study page adds new sections for How to Read a Study Record, Common Questions, and How to Join a Study, and updates the Intervention/Treatment labeling; the Revision line updates from v3.5.5 to v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-13T17:39:17.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.5.4 to v3.5.5, indicating a minor version update to the document.
    Difference
    0.0%
    Check dated 2026-06-06T14:41:48.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added Kharkiv Oblast and Kharkiv, Ukraine (61024) to the locations. Removed Kharkivs’ka Oblast’ and the corresponding Ukrainian entry.
    Difference
    0.0%
    Check dated 2026-05-30T12:21:31.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now displays a new revision tag: v3.5.4, replacing the previous v3.5.3. This indicates an update to the site’s build or content framework rather than any change to the study details.
    Difference
    0.0%
    Check dated 2026-05-15T23:51:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.